Zenrelia is an innovative, once daily treatment to break the itch-scratch cycle that lets dogs get back to normal. It is a Janus Kinase (JAK) inhibitor designed to disrupt cytokine signaling pathways that trigger itch and inflammation related to canine allergic and atopic dermatitis.

Indications

Zenrelia is indicated for the control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.

Dosage and Administration

The dose of Zenrelia (ilunocitinib tablets) is 0.27 to 0.36mg Ilunocitinib/lb (0.6 to 0.8mg ilunocitinib/kg) body weight, administered orally, once daily, with or without food.

Packaging 

3 sizes available:  4.8mg (ZE1503), 6.4mg (ZE1504), 8.5mg (ZE1504)

30 tabs/box